Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO6868847 bioequivalence and food-effect crossover study in healthy adults
NL-OMON51381Completed
- Sponsor
- Roche
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vicasinabin in diabetic retinopathy (DR), sponsored by Roche. Started Aug 2022; status: completed.
02
Drugs
vicasinabin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NL-OMON51381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51381.